Tout arrive en France, especially for folks following recent intellectual property news. The European Court of Human Rights (ECHR) released a key judgment in January in a case that pitted copyright against freedom of expression.

Posted in Commercialization, Contracts, Copyright, copyright reform, Design, European Union, Fashion Industry, Freedom of Speech, Human Rights, Image, Infringement, IP, Ownership, Supreme Court of Canada, Uncategorized
Comments: 0

The Myriad Genetics gene patenting saga has officially shaped international jurisprudence, with the Federal Court of Australia upholding the patents for BRCA1 and BRCA2. In Cancer Voices Australia v. Myriad Genetics, NSD643/2010, Federal Court of Australia (Sydney), the first Australian case to deal with the issue of gene patents, the Court took a similarly liberal [...]

Posted in Access to Medicines, Competition, Human Rights, IP, Patent Practice, Patentability, Patents
Comment: 1

“It is a truth universally acknowledged that a single culture in possession of good traditional knowledge must be in want of intellectual property rights.”

Posted in Canada, Commercialization, Copyright, Digital Libraries, Human Rights, IP, IP Reform, Moral Rights, Ownership, Patents, Social Justice, Trademarks, WIPO
Comments: 0

The long battle in the American courts over Myriad Genetics’ patents of BRCA1 and BRCA2, the primary diagnostic genes for hereditary breast and ovarian cancer has been well-documented in the IPilogue (see coverage by Beatrice yesterday as well as previous posts here, here, and here). Now, Myriad is poised to defend their patents at the Supreme Court for a second time, with [...]

Posted in Blogs, Commercialization, Competition, European Union, Human Rights, Innovation, Patent Practice, Patentability, Patents, Regulatory Policy, Trade Secrets, US
Comments 2